Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice

Biosci Biotechnol Biochem. 2019 Aug;83(8):1514-1522. doi: 10.1080/09168451.2018.1562877. Epub 2018 Dec 30.

Abstract

Koji, which is manufactured by proliferating non-pathogenic fungus Aspergillus oryzae on steamed rice, is the base for Japanese traditional fermented foods. We have revealed that koji and related Japanese fermented foods and drinks such as amazake, shio-koji, unfiltered sake and miso contain abundant glycosylceramide. Here, we report that feeding of koji glycosylceramide to obese mice alters the cholesterol metabolism . Liver cholesterol was significantly decreased in obese mice fed with koji glycosylceramide. We hypothesized that their liver cholesterol was decreased because it was converted to bile acids. Consistent with the hypothesis, many bile acids were increased in the cecum and feces of obese mice fed with koji glycosylceramide. Expressions of CYP7A1 and ABCG8 involved in the metabolism of cholesterol were significantly increased in the liver of mice fed with koji glycosylceramide. Therefore, it was considered that koji glycosylceramide affects the cholesterol metabolism in obese mice.

Keywords: : Japanese fermented foods; bile acid secretion; glycosylceramide; liver cholesterol.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 8 / metabolism
  • Animals
  • Aspergillus oryzae / metabolism
  • Bile Acids and Salts / metabolism
  • Ceramides / administration & dosage*
  • Cholesterol / metabolism*
  • Cholesterol 7-alpha-Hydroxylase / metabolism
  • Fermented Foods*
  • Japan
  • Lipoproteins / metabolism
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese

Substances

  • ABCG8 protein, mouse
  • ATP Binding Cassette Transporter, Subfamily G, Member 8
  • Bile Acids and Salts
  • Ceramides
  • Lipoproteins
  • Cholesterol
  • Cholesterol 7-alpha-Hydroxylase
  • Cyp7a1 protein, mouse